Compare TKNO & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKNO | QTRX |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.1M | 160.0M |
| IPO Year | 2021 | 2017 |
| Metric | TKNO | QTRX |
|---|---|---|
| Price | $4.60 | $3.35 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 148.2K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.86 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,520,000.00 | $37,632,000.00 |
| Revenue This Year | $8.27 | $25.49 |
| Revenue Next Year | $13.13 | $10.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.35 | ★ 64.52 |
| 52 Week Low | $1.91 | $2.40 |
| 52 Week High | $6.68 | $8.77 |
| Indicator | TKNO | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 54.84 |
| Support Level | $3.64 | $3.18 |
| Resistance Level | $4.94 | $3.74 |
| Average True Range (ATR) | 0.51 | 0.30 |
| MACD | 0.07 | 0.13 |
| Stochastic Oscillator | 49.36 | 58.90 |
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.